Cough Medicine Market
Global Cough Medicine Market Size, Share & Trends Analysis Report by Product Type (Expectorants, Antihistamines, Decongestants & Antibiotics), by Age Group (Pediatric, Adult) and by Distribution Channel (Retail Pharmacy, Hospital Pharmacy, & Online pharmacy) Forecast 2022-2028 Update Available - Forecast 2024-2030
The global cough medicine market is expected to grow at a CAGR of nearly 3.2% during the forecast period. (2022-2028). Cough syrup is a combination of drugs that are used to provide temporary relief from coughing, common cold, hay fever, and other allergies. It is produced using non-opioid cough suppressants, expectorants, and antihistamine compounds to prevent symptoms. Cough syrups are divided into two parts such as dry cough and chesty cough.
Increasing geriatric population, which is more prone to cough and colds, increased vehicle pollution, surge in demand for over-the-counter products, increased R&D activities, and increased awareness about advanced medicines are expected to help the cough remedies market generate higher revenue in the coming years. According to the United Nations Globe Population Prospects 2019 report, one in every six people in the world will be 65 or older by 2050, up from one in every eleven in 2019, and one in every four people in Europe and Northern America will be 65 or older by 2050. During the forecast period, an increase in the number of testing and research facilities, primarily in the field of biotechnology and pharmaceutical industries, contributes to considerable market growth.
Impact of COVID-19 on Global Cough Medicine Market
The COVID-19 has impacted the global economy due to a slowdown in the manufacturing of various industries. The government across the globe imposed lockdown, shutting down or reducing transport and travel to curb the spraed of virus. In addition, the lockdown affected the manufacturing, supply, and distribution of medicines, leading to constraints in the global medicines supply chain. However, the demand has increased for some medicines including cough syrups in patients with COVID-19. Cough treatment is in high demand as a result of the COVID-19 pandemic, as cough is the most prevalent symptom of the virus. It has included some anesthetics, antibiotics and muscle relaxants, and some medicines used off-label. This contributed to shortages.
Segmental Outlook
The global cough medicine market is segmented based on the product type, age group, and distribution channel. Based on the product type, the market is segmented into expectorants, antihistamines, decongestants & antibiotics. Based on the age group, the market is sub-segmented into a pediatric, adult. Based on distribution channels the market is sub-segmented into retail pharmacy, hospital pharmacy & online pharmacy. The above-mentioned segments can be customized as per the requirements. The children segment is to register robust growth over the forecast period owing to the increased lung problems and respiratory allergies among children across the globe.
Global Cough Medicine Market Share by Age Group, 2021 (%)
The Adult Segment is Anticipated to Hold a Prominent Share in the Global Cough Medicine Market
Adult segment is anticipated to hold the largest share in the market. Chronic cough is a frequent problem among the general public, as well as one of the most prevalent reasons for seeking medical help. It affects about 10% of the adult population worldwide and is linked to poor quality of life. The advances in a cough medicine that can be used in adults are expected to stimulate the growing demand for cough medicine. In March 2021, Merck announced that the Food Drug Administration (FDA) has accepted its New Drug Application (NDA) for gefapixant, an experimental, orally given, selective P2X3 receptor antagonist, for the treatment of refractory chronic cough (RCC) or unexplained chronic cough (UCC) in adults for review.
Regional Outlooks
The global cough medicine market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East &Africa, and Latin America). The market can be analyzed for a particular region or country level as per the requirement. The North American regional cough medicine market is expected to hold a prominent market share due to the presence of several key market players.
Global Cough Medicine Market Growth, by Region 2022-2028
The North America Region is Estimated to Hold Major Share in the Global Cough Medicine Market
The North American region is anticipated to hold prominent share in the cough medicine market owing to the prevalence of the chronic cough and the presence of key global players in the region. Chronic cough, defined as a cough that lasts longer than eight weeks, affects about 5% of persons in the US. Patients with RCC or UCC either do not react to therapy of underlying disease (such as asthma or gastric reflux) or have no detectable underlying condition despite a thorough evaluation. However, there are no approved medicines for the treatment of RCC or UCC at the moment, which in turn increases the demand for cough medicine in the region.
Market Players Outlook
The major companies serving the global cough medicine market include AstraZeneca plc, GlaxoSmithKline plc, Novartis International AG, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in October 2020, GSK Consumer Healthcare announced the launch of the Robitussin Naturals. It is the brand's first-ever line of drug-free products that provide relief from the occasional cough.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global cough medicine market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1.Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Impact of COVID-19 on the Global Cough Medicine Market
- Recovery Scenario of Global Cough Medicine Market
1.1.Research Methods and Tools
1.2.Market Breakdown
1.2.1.By Segments
1.2.2.BY Region
2.Market Overview and Insights
2.1.Scope of the Report
2.2.Analyst Insight & Current Market Trends
2.2.1.Key Findings
2.2.2.Recommendations
2.2.3.Conclusion
3.Competitive Landscape
3.1.AstraZeneca plc
3.1.1.Overview
3.1.2.Financial Analysis
3.1.3.SWOT Analysis
3.1.4.Recent Developments
3.2.GlaxoSmithKline plc
3.2.1.Overview
3.2.2.Financial Analysis
3.2.3.SWOT Analysis
3.2.4.Recent Developments
3.3.Merck KGaA
3.3.1.Overview
3.3.2.Financial Analysis
3.3.3.SWOT Analysis
3.3.4.Recent Developments
3.4.Novartis International AG
3.4.1.Overview
3.4.2.Financial Analysis
3.4.3.SWOT Analysis
3.4.4.Recent Developments
3.5.Pfizer Inc.
3.5.1.Overview
3.5.2.Financial Analysis
3.5.3.SWOT Analysis
3.5.4.Recent Developments
3.6.Key Strategy Analysis
3.7.Impact of Covid-19 on Key Players
4.Market Segmentation
4.1.Global Cough Medicine Market by Product Type
4.1.1.Expectorants
4.1.2.Antihistamines
4.1.3.Decongestants
4.1.4.Antibiotics
4.2.Global Cough Medicine Market by Age Group
4.2.1.Pediatric
4.2.2.Adult
4.3.Global Cough Medicine Market by Distribution Channel
4.3.1.Retail Pharmacy
4.3.2.Hospital Pharmacy
4.3.3.Online Pharmacy
5.Regional Analysis
5.1.North America
5.1.1.United States
5.1.2.Canada
5.2.Europe
5.2.1.UK
5.2.2.Germany
5.2.3.Italy
5.2.4.Spain
5.2.5.France
5.2.6.Rest of Europe
5.3.Asia-Pacific
5.3.1.China
5.3.2.India
5.3.3.Japan
5.3.4.South Korea
5.3.5.Rest of Asia-Pacific
5.4.Rest of the World
6.Company Profiles
6.1.Abbott Laboratories
6.2.Acella Pharmaceuticals, LLC
6.3.Atley Pharmaceuticals Inc
6.4.GlaxoSmithKline Plc.
6.5.Johnson & Johnson Service Inc.
6.6.Merck KGaA
6.7.Novartis International AG
6.8.Pfizer Inc.
6.9.Procter & Gamble
6.10.Reckitt Benckiser Group Plc.
6.11.Sanofi
6.12.Vertical Pharmaceutical LLC
6.13.Toray Industries Inc.
1.GLOBAL COUGH MEDICINE MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2021-2028 ($ MILLION)
2.GLOBAL EXPECTORANTS COUGH MEDICINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3.GLOBAL ANTITHISTAMINES COUGH MEDICINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4.GLOBAL DECONGESTANTS COUGH MEDICINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
5.GLOBAL ANTIBIOTICS COUGH MEDICINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6.GLOBAL COUGH MEDICINE MARKET RESEARCH AND ANALYSIS BY AGE GROUP, 2021-2028 ($ MILLION)
7.GLOBAL PEDIATRIC COUGH MEDICINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
8.GLOBAL ADULT COUGH MEDICINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
9.GLOBAL COUGH MEDICINE MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
10.GLOBAL RETAIL PHARMACY COUGH MEDICINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
11.GLOBAL HOSPITAL PHARMACY COUGH MEDICINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
12.GLOBAL ONLINE PHARMACY COUGH MEDICINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
13.GLOBAL COUGH MEDICINE MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
14.NORTH AMERICAN COUGH MEDICINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
15.NORTH AMERICAN COUGH MEDICINE MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2021-2028 ($ MILLION)
16.NORTH AMERICAN COUGH MEDICINE MARKET RESEARCH AND ANALYSIS BY AGE GROUP, 2021-2028 ($ MILLION)
17.NORTH AMERICAN COUGH MEDICINE MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNELS, 2021-2028 ($ MILLION)
18.EUROPEAN COUGH MEDICINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
19.EUROPEAN COUGH MEDICINE MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2021-2028 ($ MILLION)
20.EUROPEAN COUGH MEDICINE MARKET RESEARCH AND ANALYSIS BY AGE GROUP, 2021-2028 ($ MILLION)
21.EUROPEAN COUGH MEDICINE MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
22.ASIA-PACIFIC COUGH MEDICINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
23.ASIA-PACIFIC COUGH MEDICINE MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2021-2028 ($ MILLION)
24.ASIA-PACIFIC COUGH MEDICINE MARKET RESEARCH AND ANALYSIS BY AGE GROUP, 2021-2028 ($ MILLION)
25.ASIA-PACIFIC COUGH MEDICINE MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
26.REST OF THE WORLD COUGH MEDICINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
27.REST OF THE WORLD COUGH MEDICINE MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2021-2028 ($ MILLION)
28.REST OF THE WORLD COUGH MEDICINE MARKET RESEARCH AND ANALYSIS BY AGE GROUP, 2021-2028 ($ MILLION)
29.REST OF THE WORLD COUGH MEDICINE MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
1.IMPACT OF COVID-19 ON GLOBAL COUGH MEDICINE MARKET, 2021-2028 ($ MILLION)
2.IMPACT OF COVID-19 ON GLOBAL COUGH MEDICINE MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3.RECOVERY OF GLOBAL COUGH MEDICINE MARKET, 2021-2028 (%)
4.GLOBAL COUGH MEDICINE MARKET SHARE BY PRODUCT TYPE, 2021 VS 2028 (%)
5.GLOBAL EXPECTORANTS COUGH MEDICINE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
6.GLOBAL ANTITHISTAMINES COUGH MEDICINE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
7.GLOBAL DECONGESTANTS COUGH MEDICINE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
8.GLOBAL ANTIBIOTICS COUGH MEDICINE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
9.GLOBAL COUGH MEDICINE MARKET SHARE BY AGE GROUP, 2021 VS 2028 (%)
10.GLOBAL PEDIATRIC COUGH MEDICINE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
11.GLOBAL ADULT COUGH MEDICINE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
12.GLOBAL COUGH MEDICINE MARKET SHARE BY DISTRIBUTION MARKET, 2021 VS 2028 (%)
13.GLOBAL RETAIL PHARMACY COUGH MEDICINE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
14.GLOBAL HOSPITAL PHARMACY COUGH MEDICINE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
15.GLOBAL ONLINE PHARMACY COUGH MEDICINE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
16.GLOBAL COUGH MEDICINE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
17.US COUGH MEDICINE MARKET SIZE, 2021-2028 ($ MILLION)
18.CANADA COUGH MEDICINE MARKET SIZE, 2021-2028 ($ MILLION)
19.UK COUGH MEDICINE MARKET SIZE, 2021-2028 ($ MILLION)
20.FRANCE COUGH MEDICINE MARKET SIZE, 2021-2028 ($ MILLION)
21.GERMANY COUGH MEDICINE MARKET SIZE, 2021-2028 ($ MILLION)
22.ITALY COUGH MEDICINE MARKET SIZE, 2021-2028 ($ MILLION)
23.SPAIN COUGH MEDICINE MARKET SIZE, 2021-2028 ($ MILLION)
24.REST OF EUROPE COUGH MEDICINE MARKET SIZE, 2021-2028 ($ MILLION)
25.INDIA COUGH MEDICINE MARKET SIZE, 2021-2028 ($ MILLION)
26.CHINA COUGH MEDICINE MARKET SIZE, 2021-2028 ($ MILLION)
27.JAPAN COUGH MEDICINE MARKET SIZE, 2021-2028 ($ MILLION)
28.SOUTH KOREA COUGH MEDICINE MARKET SIZE, 2021-2028 ($ MILLION)
29.REST OF ASIA-PACIFIC COUGH MEDICINE MARKET SIZE, 2021-2028 ($ MILLION)
30.REST OF THE WORLD COUGH MEDICINE MARKET SIZE, 2021-2028 ($ MILLION)
